Literature DB >> 29443189

Temporal arteritis.

Andrew W Lee1, Celia Chen1, Sudha Cugati1.   

Abstract

Temporal or giant cell arteritis is an inflammation of medium and small extracranial vessels that may result in ocular ischemia, an aortitis followed by aortic dissection and peripheral limb ischemia. It should be considered a medical emergency due to the seriousness of end organ damage, in particular visual symptoms. While the presentation may be nonspecific, the presence of a tender temporal artery mandates a temporal artery biopsy. High-dose steroids should be begun the moment the diagnosis is considered and only withdrawn once it has been excluded. A gradual tapering of the steroid dose should occur over at least 1 year, with the consideration of the use of steroid-sparing agents if iatrogenic steroid complications occur. Careful monitoring of the response both clinically as well as with serial inflammatory markers is required.

Entities:  

Year:  2014        PMID: 29443189      PMCID: PMC5765614          DOI: 10.1212/CPJ.0b013e3182a9c62a

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  26 in total

1.  BSR and BHPR guidelines for the management of giant cell arteritis.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Leslie Alexander; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Pat James; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

Review 2.  Giant cell arteritis.

Authors:  Xiang Wang; Zhi Ping Hu; Wei Lu; Xiang Q Tang; He P Yang; Liu W Zeng; Jie Zhang; Ting Li
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

3.  Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis.

Authors:  Ann P Murchison; Molly E Gilbert; Jurij R Bilyk; Ralph C Eagle; Victoria Pueyo; Robert C Sergott; Peter J Savino
Journal:  Am J Ophthalmol       Date:  2012-07-17       Impact factor: 5.258

4.  Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.

Authors:  Cyrielle Assie; Alain Janvresse; Didier Plissonnier; Hervé Levesque; Isabelle Marie
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 5.  Diagnosis and management of giant cell arteritis: a review.

Authors:  Nilufer Kale; Eric Eggenberger
Journal:  Curr Opin Ophthalmol       Date:  2010-11       Impact factor: 3.761

6.  Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET.

Authors:  M Czihal; F Tatò; S Förster; A Rademacher; H Schulze-Koops; U Hoffmann
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

7.  Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Angela Piñeiro; Robustiano Pego-Reigosa; Javier Llorca; Gene G Hunder
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

8.  The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

Authors:  B A Bengtsson; B E Malmvall
Journal:  Arthritis Rheum       Date:  1981-07

9.  Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.

Authors:  Anne Proven; Sherine E Gabriel; Carlos Orces; W Michael O'Fallon; Gene G Hunder
Journal:  Arthritis Rheum       Date:  2003-10-15

Review 10.  Giant cell arteritis.

Authors:  S S L Chew; N M Kerr; H V Danesh-Meyer
Journal:  J Clin Neurosci       Date:  2009-07-07       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.